- Home
- CAPL vs CVAC Comparison
CAPL vs CVAC Comparison
Compare CAPL & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPL
- CVAC
- Stock Information
- Founded
- CAPL 1992
- CVAC 2000
- Country
- CAPL United States
- CVAC Germany
- Employees
- CAPL N/A
- CVAC N/A
- Industry
- CAPL Oil Refining/Marketing
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- CAPL Energy
- CVAC Health Care
- Exchange
- CAPL Nasdaq
- CVAC Nasdaq
- Market Cap
- CAPL 804.3M
- CVAC 643.8M
- IPO Year
- CAPL 2012
- CVAC 2020
- Fundamental
- Price
- CAPL $21.49
- CVAC $2.82
- Analyst Decision
- CAPL
- CVAC Hold
- Analyst Count
- CAPL 0
- CVAC 3
- Target Price
- CAPL N/A
- CVAC $10.00
- AVG Volume (30 Days)
- CAPL 22.8K
- CVAC 399.6K
- Earning Date
- CAPL 11-05-2024
- CVAC 11-12-2024
- Dividend Yield
- CAPL 9.77%
- CVAC N/A
- EPS Growth
- CAPL N/A
- CVAC N/A
- EPS
- CAPL 0.56
- CVAC N/A
- Revenue
- CAPL $3,996,818,000.00
- CVAC $70,565,734.00
- Revenue This Year
- CAPL $14.36
- CVAC $105.61
- Revenue Next Year
- CAPL N/A
- CVAC N/A
- P/E Ratio
- CAPL $38.30
- CVAC N/A
- Revenue Growth
- CAPL N/A
- CVAC 75.11
- 52 Week Low
- CAPL $18.43
- CVAC $2.22
- 52 Week High
- CAPL $24.19
- CVAC $6.30
- Technical
- Relative Strength Index (RSI)
- CAPL 56.40
- CVAC 38.84
- Support Level
- CAPL $21.54
- CVAC $2.79
- Resistance Level
- CAPL $21.97
- CVAC $2.89
- Average True Range (ATR)
- CAPL 0.30
- CVAC 0.11
- MACD
- CAPL 0.00
- CVAC -0.01
- Stochastic Oscillator
- CAPL 63.31
- CVAC 19.44
About CAPL CrossAmerica Partners LP Common Units representing limited partner interests
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver, includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K and through company operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites and the retail sale of motor fuel at retail sites operated by commission agents.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.